This award was created in honor of Allen. S. Lichter, MD, FASCO, to recognize ASCO members who have transformed the oncology field or significantly advanced the mission of ASCO, the Conquer Cancer Foundation, or CancerLinQ, LLC, through their leadership, vision, and ability to inspire.
An ASCO member since 1980, Dr. Lichter served the Society in several prominent volunteer roles, including President (1998-1999), Founding Chairman of the Conquer Cancer Foundation Board of Directors (1999), and Chief Executive Officer (2006-2016). In his ten years as CEO, Dr. Lichter has overseen the rapid growth of the Society and the launch of important new initiatives to improve the quality and value of cancer care. The Allen S. Lichter Visionary Leader Award honors Dr. Lichter’s commitment and contributions to ASCO and will continue his legacy by encouraging and recognizing extraordinary leadership in oncology.
Learn more about Dr. Lichter.
The award consists of an honorarium, a commemorative plaque, and complimentary registration and travel support to the recipient to attend the ASCO Annual Meeting. The recipient also delivers a lecture at the ASCO Annual Meeting.
Nominations are now being accepted for the 2020 Special Awards. Visit the nomination portal to submit your nominations.
To be eligible for this award, candidates must:
- be an ASCO member
- demonstrate innovative and inspirational leadership that is transforming the oncology field by promoting the highest quality patient care and improving the lives of patients with cancer; or, whose exemplary leadership, vision and commitment have significantly advanced the missions of ASCO, the Conquer Cancer Foundation, or CancerLinQ; or, whose foresight and ability to inspire the broader cancer community have helped to transform the oncology or cancer experience in a positive way
Candidates for the award are considered by the ASCO Special Awards Selection Committee. The committee considers all nominations as they have been submitted; recommendations are then forwarded to the Board of Directors for final approval.
Please send all inquiries about this award to Special Awards.